InvestorsHub Logo
Followers 44
Posts 2387
Boards Moderated 0
Alias Born 08/09/2016

Re: jessellivermore post# 103829

Tuesday, 04/04/2017 1:41:40 PM

Tuesday, April 04, 2017 1:41:40 PM

Post# of 429205
JL - They clearly could look at these all cause cost benefits of V quite easily. Something clearly changed between last year and this year in terms of insurance coverage for V (including preference over Lovaza). Without new trial results to justify this, one has to wonder what changed the "bean counters" minds??? I do not think insurance companies make changes like this for no reason, especially when (on the face of it at least) the change costs more money up front.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News